Treatment of Opioid Use Disorder in Pregnant Women via Telemedicine: A Nonrandomized Controlled Trial.

ABSTRACT:

Importance

There are high rates of maternal and newborn morbidity and mortality associated with opioid use disorder (OUD). Integrating OUD treatment in obstetric practices for pregnant and postpartum women via telemedicine can increase access to care and reduce the consequences of OUD. Evaluation of this care delivery model, however, is needed before widespread adoption.

Objective

To compare maternal and newborn outcomes among pregnant women with OUD receiving care via telemedicine vs in person.

Design, setting, and participants

A nonrandomized controlled trial including 98 women receiving perinatal OUD treatment in 4 outpatient obstetric practices by telemedicine or in person and followed up until 6 to 8 weeks post partum was conducted from September 4, 2017, to Dece

SUBMITTER: Guille C 

PROVIDER: S-EPMC7042863 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature